Navigation Links
MRI finds breast cancer before it becomes dangerous
Date:8/13/2007

A study in the Lancet (vol. 370, 11 August 2007) could lead to a change of paradigm in the early diagnosis of breast cancer. It states that magnetic resonance imaging (MRI) is substantially more accurate than mammography in diagnosing very early stages of breast cancer . Up to now MRI was thought to be hardly suited for the detection of such 'ductal carcinoma in situ (DCIS) . Researchers at the University of Bonn have now come to a completely different conclusion. In the past five years they examined more than 7000 women with both methods. In a total of 167 women the doctors found early forms of breast cancer 152 (92 %) of these were found using MRT, 93 (56 %) with mammography.

Breast cancer forms in the cells which line the inside walls of the milk ducts. The tumour initially remains in the milk duct and is therefor called " intraductal cancer" or DCIS (ductal carcinoma in situ). Although even at this stage it is called a carcinoma, it behaves actually like a benign disease, which can always be treated successfully by operating on it. Only when the tumour grows out of the milk ducts into the breasts glandular tissue can it spread via blood and lymph vessels in the body. 'If we find DCIS and remove it we can prevent the formation of real breast cancer,' the Bonn radiologist Professor Christiane Kuhl explains. 'That way we prevent the development of a disease that is often life-threatening.'

However, there are different forms of intraductal carcinomas: the less aggressive (low-grade) and highly aggressive (high-grade) DCIS. Whereas low-grade DCIS is relatively inert and may never spread beyond the milk duct (and thus may never pose a threat to the women affected), high-grade DCIS will virtually always break out of the milk ducts, and then will become dangerous, biologically aggressive high grade invasive breast cancer. This makes it all the more important to discover such high-grade DCIS.

Until To date mammography was the 'gold standard' of brea
'/>"/>

Contact: Professor Christiane Kuhl
kuhl@uni-bonn.de
49-022-828-719-875
University of Bonn
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Over Six Million HIV Infected People In South Africa- Finds A Survey
2. Its Never Too Late to Stop Smoking,Study Finds
3. Research finds new explanations for dyslexia
4. Poll Finds Many Americans Misinformed About Cancer
5. Poll Finds Many Americans Misinformed About Cancer
6. Research Finds How Post-traumatic Stress Leads to Long-Lasting Memories
7. Study Finds No Link Between Statins And Breast Cancer Risk
8. Survey finds that discussion with family very crucial in organ donation decision
9. Study finds no link between fibre and cancer risk
10. Study Finds Low Socio-Economic Status Linked to Poor Dental Health
11. Australian Court Finds Man Guilty of Spreading HIV/AIDS

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... QUINCY, Mass., Nov. 20 Following ...et Company removed from sale Shedd,s Country Crock...nd Shedd,s Country Crock ® Side Dishes DELUXE...lergen. ,, The following code dates and UPCs a...ide Dishes DELUXE Cheddar Broccoli Rice 21 oz, UPC...
(Date:11/20/2009)..., HAIFA, Israel, November 20 /PRNewswire-Fir...VSL.OB), http://www.CVSLMEDICAL.COM , a leading,d...logy, today announced that,the company,s Board of ...ons,in Europe, Canada and the Far East for its pro...licable for all angioplasty (PCTA) procedures. ,...
(Date:11/20/2009)...ations of exposure to formaldehyde used for embalm...n increased risk of death from myeloid leukemia, a...20 in the Journal of the National Cancer Institut...ty from lymphohematopoietic malignancies and brain...ndustry workers, all of whom may have worked with ...
(Date:11/20/2009)...save up to one-third buying 90-day supply, study f...) -- Buying a three-month supply of prescription d...month supply, according to a new study. , U.S. ...or 395 drugs between 2000 and 2005, and found that...of a one-month supply saved an average 29 percent ...
(Date:11/20/2009)... SPRINGFIELD, Mo., Nov. 20 Missour...al Missouri regions will now have the option to ch...ched Tuesday between Missouri Consolidated Health ...e Southwest and South Central Missouri regions inc... Christian, Dade, Dallas, Douglas, Greene, Hickory...
Breaking Medicine News(10 mins):Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Three-Month Supply Lowers Drug Costs 2Health News:Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option 2
...ve crafted a gene circuit that permits precise tun...hat should allow for more accurate analysis of the...ion. , This gene "dosing effect" is achieved by i...sts at The University of Texas M. D. Anderson Canc...
...-- Health information technology programs implemen... full two years after being established, and could...rding to a study by investigators at Weill Cornell...ushal, chief of the Division of Quality and Clinic...
...Stamford-based Olympus Partners is pleased to anno...orp. from The Hansen Corporate Group. Holopack In... immediately change its name to The Ritedose Corpo...ded, filled and sealed in a continuous sterile pro...
...Gundersen Lutheran is the first in the nation to a...ational Quality Measures for Breast Centers(TM) (N... a commitment to provide the highest level of qual...the measurement of breast cancer treatment and out...
...ow Pharmaceutical Marketers Can Leverage Social Me...tives , , PLEASANTON, Calif., March 10 Spigit, ...are for the enterprise, announced today that compa...he Bio/Pharmaceutical Industry at 2:30 p.m. on We...
... A diverse coalition of clergy and lay members fro... conference today to call on U.S. Senators Tom Har...ngressional delegation to support legislation that...ession of Congress, Senator Grassley was not. , ...
Other Medicine News:Health News:Synthetic gene circuit allows precise dosing of gene expression 2Health News:Synthetic gene circuit allows precise dosing of gene expression 3Health News:New York State health IT strategy may be model for the nation 2Health News:New York State health IT strategy may be model for the nation 3Health News:Gundersen Lutheran Breast Center Earns Top National Honor 2Health News:Spigit Enterprise Community Expert to Highlight Enterprise 2.0 Apps for Pharma Companies at Annual CBI eMarketing Forum 2Health News:Spigit Enterprise Community Expert to Highlight Enterprise 2.0 Apps for Pharma Companies at Annual CBI eMarketing Forum 3Health News:Faith Leaders Call on Iowa Members of Congress to Support Legislation to Protect Kids from Tobacco 2Health News:Faith Leaders Call on Iowa Members of Congress to Support Legislation to Protect Kids from Tobacco 3
(Date:11/20/2009)..., MINNEAPOLIS, Nov. 20 B...sults for its first quarter ended September 30, 20...uted share, on revenues of $3,263,000. This compa...ted share, on revenues of $3,168,000 for the first...st quarter results, Biotel President and CEO Steve...
(Date:11/20/2009)..., PRINCETON, N.J., Nov. 20 /PRNewswire-FirstCal...Soligenix or the Company), formerly known as DOR B..., announced today that it has formed a consortium ...x(TM) and other rapidly acting vaccines. Soligenix...nstitute of Allergy and Infectious Diseases (NIAID...
(Date:11/19/2009)..., TAINAN, Taiwan, Nov. 19 /PRNewswire-Asia/...e pharmaceutical ingredients (APIs), announced tha...ound Safety Certification from,SafeBridge(R) Consu...,s,competency and proficiency in the safe handling...), and applies to specific laboratories and,produc...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Doctors Efforts to Fight Childhood Obesity Not Working 56256 1Nurses and Retirement Security 3A A Looming Crisis 3F 56253 1Nurses and Retirement Security 3A A Looming Crisis 3F 56253 2Nurses and Retirement Security 3A A Looming Crisis 3F 56253 3Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government 13861 1Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government 13861 2Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government 13861 3
...(Nasdaq: CRGN ), a clinical-stage biopharmaceutic... (Copenhagen Stock Exchange: TOPO) announced,today...rom the Phase II,study of belinostat for T-cell ly...ostat on pediatric leukemia cell lines, will be pr... (ASH) 49th Annual Meeting in,Atlanta, GA, on Mond...
...VELCADE in front-line, multiple myeloma to be fe... Society of Hematology (ASH) Annual Meeting...euticals, Inc. (Nasdaq: MLNM ) today announced th...E clinical studies are scheduled to be,featured at...December 8-11,2007. The data will highlight the si...
Other Medicine Technology:CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 2CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 3CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 4CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 5New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma 2New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma 3New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma 4New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma 5New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma 6
Maverick Over-The-Wire 25 mm Catheter
Maverick Over-The-Wire 15 mm Catheter
...ated Phoroptor features lighted dials to make it e... the darkened setting of the exam room. Put away y...the entire process. The Illuminated Phoroptor feat...xis scales that are easier than ever to see. The I...
Illuminated PHOROPTOR Refracting Instrument - Plus Cylinder Black
Medicine Products: